Article Information
PubMed
Published By
History
- Received April 15, 2020
- Accepted July 2, 2020
- Published online August 31, 2020.
Copyright & Usage
Copyright © 2020 American Society for Microbiology. All Rights Reserved.
Editors and / or Reviewers
- Lawrence Banks, Editor, International Centre for Genetic Engineering and Biotechnology
Article Versions
- Accepted Manuscript version (July 08, 2020).
- You are viewing the most recent version of this article.
Author Information
- Cason R. Kinga,
- Tanner M. Tessiera,
- Mackenzie J. Dodgea,
- Jason B. Weinbergb,c and
- Joe S. Mymryka,d,e
- aDepartment of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada
- bDepartment of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA
- cDepartment of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA
- dDepartment of Oncology, University of Western Ontario, London, Ontario, Canada
- eLondon Regional Cancer Program and Lawson Health Research Institute, London, Ontario, Canada
- Address correspondence to Joe S. Mymryk, jmymryk{at}uwo.ca.
Cason R. King and Tanner M. Tessier contributed equally. Author order was determined based on seniority.
Citation King CR, Tessier TM, Dodge MJ, Weinberg JB, Mymryk JS. 2020. Inhibition of human adenovirus replication by the importin α/β1 nuclear import inhibitor ivermectin. J Virol 94:e00710-20. https://doi.org/10.1128/JVI.00710-20.